SXTP 60 Degrees Pharmaceuticals, Inc.
Healthcare$1.50+1.35%ClosedMarket Cap: $1.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.53
P/S
1.19
EV/EBITDA
0.27
DCF Value
$-28.19
FCF Yield
-688.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
20.9%
Operating Margin
-791.1%
Net Margin
-755.2%
ROE
-200.2%
ROA
-112.1%
ROIC
-162.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $162.1K | 47.1% | $-2.1M | $-2.1M | $— | — |
| Q4 null | $303.4K | 60.2% | $-1.9M | $-1.4M | $— | — |
| FY null | $1.0M | 22.3% | $-7.8M | $-7.4M | $— | — |
| Q3 null | $437.6K | -22.9% | $-2.3M | $-2.3M | $— | — |
| Q2 null | $100.9K | 50.4% | $-1.6M | $-1.7M | $— | — |
| Q1 null | $163.6K | 55.2% | $-1.9M | $-1.9M | $— | — |
| Q4 null | $261.4K | 54.8% | $-2.1M | $-2.0M | $— | — |
| FY null | $607.6K | 36.7% | $-9.7M | $-7.9M | $— | — |
| Q3 null | $135.3K | 17.4% | $-2.1M | $-2.2M | $— | — |
| Q2 null | $125.0K | 28.3% | $-4.2M | $-4.2M | $— | — |
| Q1 null | $105.7K | 38.1% | $-1.3M | $430.5K | $— | — |
| Q4 2023 | $42.7K | -242.5% | $-1.9M | $-2.0M | $-1.36 | — |